ArticleCancer informatics2023

A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.

Shubhadeep D Sinha et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.